CORK, IRELAND — (Marketwired) — 09/04/13 — , the leading provider of regulatory, quality, and compliance management solutions to the Life Sciences industry, today announced that (SHL), the world-s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, has selected on to manage regulatory content, SOPs and change control.
QUMAS ComplianceSP provides SHL with a proven and flexible Quality Management Solution that delivers a comprehensive set of capabilities around compliant document and process management. All of the capabilities are accessed through the familiar Microsoft SharePoint user interface allowing the solution to be deployed with minimal training. ComplianceSP is fully web-based, ensuring anytime/anywhere access to compliance activities and is secured by role and permission based access.
, a QUMAS channel partner, will be responsible for rolling out the ComplianceSP solution to over 900 users based in Taiwan, Sweden, China, and the United States. The rollout includes qualification of the SharePoint platform and validation of ComplianceSP.
“Regulations are changing all the time, and we wanted to make sure that we selected a solution that could meet not only our current requirements, but our future needs as well,” stated Ulrich Faessler, Director at SHL. “A major reason for selecting the QUMAS SharePoint solution is that it provides a best practice that is also configurable, allowing us to make our own adjustments to the configuration without requiring a re-validation of the solution.”
“SHL has experienced strong growth over the last several years,” said Steve Dawson, Director of Asia Pacific for QUMAS. “With our ComplianceSP solution, SHL will have a scalable solution in place that can comfortably support the future growth of the company.”
SHL is the world-s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices such as auto injectors and pen injectors. SHL has over 2,400 staff globally, with the primary design centers located in the USA and Sweden and manufacturing centers located in Asia. SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced a broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
For additional information visit .
QUMAS is the leader in Enterprise Compliance Solutions with more than 270 global customer deployments and two decades of experience helping companies in highly regulated industries. QUMAS is a Microsoft Gold Partner, and provides the QUMAS Compliance Platform on SharePoint 2010, Documentum, Oracle or SQL. For more information, visit .
MEDIA CONTACT:
Caoimhe Kiely
VP Marketing
QUMAS
+353 21 4915100
You must be logged in to post a comment Login